|
Volumn 23, Issue SUPPL. 2, 2002, Pages
|
Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain
a,c,d c,d b,c,d b,c,d a,c,d a,c,d c,d
b
IRCCS NEUROMED
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE;
8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 1 RECEPTOR BLOCKING AGENT;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR STIMULATING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
ETICLOPRIDE;
PROTEIN FOS;
QUINPIROLE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BASAL GANGLION;
BRAIN CORTEX;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SELECTIVITY;
MALE;
MODULATION;
NONHUMAN;
PARKINSON DISEASE;
PROTEIN EXPRESSION;
RAT;
(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL;
2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE;
ANIMALS;
BASAL GANGLIA;
BRAIN;
CEREBRAL CORTEX;
CORPUS STRIATUM;
DOPAMINE AGONISTS;
DOPAMINE ANTAGONISTS;
MALE;
ONCOGENE PROTEINS V-FOS;
QUINPIROLE;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DOPAMINE;
RECEPTORS, DOPAMINE D1;
RECEPTORS, DOPAMINE D2;
SALICYLAMIDES;
|
EID: 0036756966
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s100720200068 Document Type: Article |
Times cited : (2)
|
References (8)
|